Serum Testosterone Level on Angiographic Complexity of Coronary Lesions in Premature Ischemic Egyptian Males
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
AgeUp to 45
SponsorSohag University
About this trial
This study aims to investigate the association between serum testosterone levels and the angiographic complexity of coronary artery lesions in male patients under 45 years of age presenting with premature ischemic heart disease.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male patients aged <45 years.
Diagnosed with premature ischemic heart disease.
Undergoing elective coronary angiography for suspected coronary artery disease (CAD) .
Disqualifiers
History of acute coronary syndrome within the preceding 3 months.
Prior diagnosis of hypogonadism or history of testosterone replacement therapy or anabolic steroid use.
Active neoplasm or history of chemotherapy.
Known hepatic cirrhosis, chronic kidney disease, or end-stage renal disease.
Trial population
This prospective study will be conducted at Sohag University Hospitals after approval from the institutional ethical committee.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Coronary Angiography
Other interventionAll angiographic procedures will be performed. Coronary artery disease will be defined as \>70% stenosis in at least one major epicardial artery or \>50% the left main coronary artery.
Syntax Score
Other interventionThe angiographic complexity of coronary artery disease (CAD) will be assessed using the SYNTAX score.
Treatment groups
50 Participants
are divided into 2 treatment groupsGroup A: Significant coronary artery disease (CAD) group2 interventions
Group B: Non-significant coronary artery disease (CAD) group2 interventions
Trial outcomes
Primary outcomes
1
Serum testosterone level
Serum testosterone level will be measured.
Time frame
Immediately after angiography (Up to 1 hour)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov